Natural course of neuropsychiatric symptoms in nursing home patients with mental-physical multimorbidity in the first eight months after admission by van den Brink, Anne et al.
  
 University of Groningen
Natural course of neuropsychiatric symptoms in nursing home patients with mental-physical
multimorbidity in the first eight months after admission
van den Brink, Anne; Gerritsen, Debby L; de Valk, Miranda M H; Oude Voshaar, Richard;
Koopmans, Raymond
Published in:
AGING & MENTAL HEALTH
DOI:
10.1080/13607863.2018.1531384
IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
2020
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
van den Brink, A., Gerritsen, D. L., de Valk, M. M. H., Oude Voshaar, R., & Koopmans, R. (2020). Natural
course of neuropsychiatric symptoms in nursing home patients with mental-physical multimorbidity in the
first eight months after admission. AGING & MENTAL HEALTH, 24(1), 155-161.
https://doi.org/10.1080/13607863.2018.1531384
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the
author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the
number of authors shown on this cover page is limited to 10 maximum.
Download date: 21-02-2020
Full Terms & Conditions of access and use can be found at
https://www.tandfonline.com/action/journalInformation?journalCode=camh20
Aging & Mental Health
ISSN: 1360-7863 (Print) 1364-6915 (Online) Journal homepage: https://www.tandfonline.com/loi/camh20
Natural course of neuropsychiatric symptoms
in nursing home patients with mental-physical
multimorbidity in the first eight months after
admission
Anne van den Brink, Debby L. Gerritsen, Miranda M.H. de Valk, Richard
Oude Voshaar & Raymond Koopmans
To cite this article: Anne van den Brink, Debby L. Gerritsen, Miranda M.H. de Valk, Richard Oude
Voshaar & Raymond Koopmans (2018): Natural course of neuropsychiatric symptoms in nursing
home patients with mental-physical multimorbidity in the first eight months after admission, Aging &
Mental Health, DOI: 10.1080/13607863.2018.1531384
To link to this article:  https://doi.org/10.1080/13607863.2018.1531384
© 2018 The Author(s). Published by Informa
UK Limited, trading as Taylor & Francis
Group
View supplementary material 
Published online: 18 Nov 2018.
Submit your article to this journal 
Article views: 217
View Crossmark data
Natural course of neuropsychiatric symptoms in nursing home patients with
mental-physical multimorbidity in the first eight months after admission
Anne M. A. van den Brinka,b , Debby L. Gerritsena, Miranda M.H. de Valkb, Richard C. Oude Voshaarc and
Raymond T. C. M. Koopmansa,b
aRadboud University Medical Center, Radboud Institute for Health Sciences, Department of Primary and Community care, Nijmegen,
Netherlands; bDe Waalboog, ’Joachim en Anna’, Center for Specialized Geriatric Care, Nijmegen, Netherlands; cUniversity Medical Center
Groningen, University Center for Psychiatry and Interdisciplinary Center for Psychopathology of Emotion regulation, Groningen,
Netherlands
ABSTRACT
Objective: Aging societies will bring an increase in the number of long-term care patients
with mental-physical multimorbidity (MPM). This paper aimed to describe the natural course of
neuropsychiatric symptoms (NPS) in patients with MPM in the first 8months after admission to a
geronto-psychiatric nursing home (GP-NH) unit.
Methods: Longitudinal cohort study among 63 patients with MPM no dementia living in 17
GP-NH units across the Netherlands. Data collection consisted of chart review, semi-structured
interviews, and brief neuropsychological testing, among which our primary outcome measure the
Neuropsychiatric Inventory (NPI). Descriptive and bivariate analyses were conducted.
Results: Our study showed a significant increase of the NPI total score (from 25.3 to 29.3,
p¼ 0.045), and the total scores of a NPI hyperactivity cluster (from 9.7 to 11.8, p¼ 0.039), and a
NPI mood/apathy cluster (from 7.7 to 10.1, p¼ 0.008). Just over 95% had any clinically relevant
symptom at baseline and/or six months later, of which irritability was the most prevalent and
persistent symptom and the symptom with the highest incidence. Hyperactivity was the most
prevalent and persistent symptom cluster. Also, depression had a high persistence.
Conclusions: Our results indicate the omnipresence of NPS of which most were found to be
persistent. Therefore, we recommend to explore opportunities to reduce NPS in NH patients with
MPM, such as creating a therapeutic milieu, educating the staff, and evaluating patient’s psycho-
tropic drug use.
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A nursing home (NH) is a facility with a domestic-styled
environment that provides 24-hour care for persons who
require assistance with activities of daily living and who
often have complex health needs due to physical as well
as psychosocial vulnerability (Sanford et al., 2015).
Nowadays, NHs are faced with a growing number of
patients with mental-physical multimorbidity (MPM). On
the one hand, this is caused by the increasing number of
elderly people with MPM that results from the rising num-
ber of elderly people in our society and MPM being com-
mon in older people (Schram et al., 2008; Singh, 2010). On
the other hand, in recent decades the total number of psy-
chiatric hospital beds has decreased dramatically (Novella,
2010). Since then, NHs have partly taken over the trad-
itional asylum function of psychiatric hospitals (Bartels,
Miles, Dums, & Levine, 2003).
Long-term care (LTC) patients with MPM constitute a
heterogeneous group. Compared to other LTC patients,
patients with MPM are more likely to be younger, male
and unmarried and more often have cognitive impairment
no dementia and neuropsychiatric symptoms (NPS) (van
den Brink, Gerritsen, Voshaar, & Koopmans, et al., 2013).
Recent studies in Dutch NHs confirmed these results and
also showed that clinically relevant NPS were highly preva-
lent in MPM patients with and without dementia as well as
chronic psychiatric and physical disorders and associated
medication use (Collet, de Vugt, Verhey, Engelen, & Schols,
2018; van den Brink, Gerritsen, de Valk, Oude Voshaar, &
Koopmans, 2017).
In the Netherlands, many NHs focus on specializing their
care to specific patient groups, among others those with
MPM. Most of these NHs house patients with MPM on
separate units, so-called geronto-psychiatric nursing
home (GP-NH) units, in contrast with among others
psycho-geriatric (dementia special care) and somatic units.
The care needs of NH patients with MPM differ from the
traditional patients in nursing homes having primarily
dementia and/or physical multimorbidity (van den Brink,
Gerritsen, Oude Voshaar, & Koopmans, 2014; van den Brink
et al., 2018; Wieczorowska-Tobis et al., 2016). In this way,
Dutch nursing homes aim to provide the most appropriate
care-environment, knowing that care that is not tailored to
the needs and preferences of a patient can have a negative
influence on NPS (Bakker et al., 2014; Slade, Leese, Cahill,
Thornicroft, & Kuipers, 2005; White et al., 1997). However,
CONTACT Anne M. A. van den Brink anne.vandenbrink@radboudumc.nl
Supplemental data for this article can be accessed at https://doi.org/10.1080/13607863.2018.1531384.
 2018 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group
This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-
nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or
built upon in any way.
AGING & MENTAL HEALTH
https://doi.org/10.1080/13607863.2018.1531384
research on how these patients fare after admission to a
GP-NH unit is lacking.
Studies investigating the course of NPS and associated
determinants have mainly focused on people with demen-
tia. These studies, that were conducted in various settings,
showed that an increase of NPS was associated with a
decline in cognitive functioning, and with the use of psy-
chotropic drugs and the level of NPS at baseline (Aalten,
de Vugt, Jaspers, Jolles, & Verhey, 2005; Brodaty, Connors,
Xu, Woodward, & Ames, 2015; Selbaek, Engedal, Benth, &
Bergh, 2014; Wetzels, Zuidema, de Jonghe, Verhey, &
Koopmans, 2010). In a study in patients with young-onset
dementia, high levels of unmet needs and higher educa-
tion were associated with an increase of NPS over time
(Bakker et al., 2014).
Also in patients with MPM no dementia, NPS are a sub-
stantial challenge for their carers (van den Brink et al., 2017).
Knowledge about the prevalence and course of NPS in these
patients is important for being able to plan and realize
adequate care in a supportive environment, to arrange the
necessary staff education, and to inform patients and their
families about prognosis and treatment approaches.
Therefore, the aim of this study is to describe the
change in NPS over the first eight months of institutional-
ization at a GP-NH unit and associations with change in
NPS between two measurements in this period. Since
changes in psychotropic drug use (PDU) could have an
impact on NPS, we also describe PDU and its changes.
Methods
The MAPPING study (patients with both Mental And
Physical Problems residing In Dutch NursinG homes) is a
cohort study with a follow up of six months. The design of
the MAPPING study has been described extensively else-
where (van den Brink et al., 2017) but will be summar-
ized below.
Participants
Participants were recruited from 17 Dutch NHs with a
geronto-psychiatric unit. The study population consisted of
NH patients, newly admitted to one of these units, with
somatic illness and persistent psychiatric disorders or severe
behavioural problems. Patients were included if (1) they
needed both physical and psychiatric care, as shown in the
medical history, and (2) the psychiatric or behavioural prob-
lems had been present for 2 years or longer without pro-
spect of substantial recovery. Exclusion criteria were:
(1) dementia, (2) inability to give informed consent, (3) a
mental or physical illness too severe for reliable data collec-
tion, and (4) refusal to participate. The physician of the GP-
NH unit applied the in- and exclusion criteria and deter-
mined whether a patient was eligible for participating in
the study. If so, written informed consent was requested
from the patient.
Ethical considerations
Formal approval according to the Medical Research
Involving Human Subjects Act was not necessary, as estab-
lished by the local Medical Ethics Review Committee ‘CMO
Regio Arnhem-Nijmegen’, that has reviewed the study
protocol (number 2011/171). NH management boards gave
permission for the study, which was conducted in accor-
dance with the Declaration of Helsinki and the Code of
Conduct for Health Research (2004) as well as the rules
applicable in the Netherlands.
Data collection
Data collection took place between April 2012 and July
2015 and was carried out by the researcher (AvdB) and a
research assistant (MdV). Both are certified elderly care
physicians (Koopmans, Pellegrom, & van der Geer, 2017).
Beforehand they were trained in administering the assess-
ment instruments.
NH patients and licensed nurses specifically assigned to
individual patients for care management purposes were
interviewed twice: six to nine weeks after admission of the
patient (T0) and six months (plus/minus 3weeks) later (T1).
Data collection consisted of chart review, semi-struc-
tured interviews, (brief) neuropsychological testing, and
self-report questionnaires. Medical and demographic data
were collected from the patients’ medical file.
Demographic characteristics were the patient’s age, sex,
ethnicity, marital status, level of education and residence
prior to admission to the nursing home.
Data on psychotropic drug use on the day of assess-
ment were retrieved from pharmacy files. Drugs were clas-
sified using the Anatomical Therapeutic Chemical
classification (Nordic Councel on Medicines 1990.
Guidelines for ATC Classification. WHO collaborating Center
for Drugs Statistic Methodology) and grouped into antipsy-
chotics, anxiolytics, hypnotics, antidepressants, anti-epilep-
tics, and other psychotropic drugs. Prescriptions for
incidental use were not involved.
Primary outcome: neuropsychiatric symptoms
NPS were assessed with the Neuropsychiatric Inventory
Nursing Home version (NPI-NH). The NPI-NH is a modified
version of the Neuropsychiatric Inventory (Cummings et al.,
1994) originally designed to measure psychiatric symptoms
in geriatric patients with dementia. The NH version was
developed for use by professional caregivers within institu-
tions and was found to be valid and reliable when adminis-
tered by trained nursing staff (Wood et al., 2000). The NPI-
NH can also be used to screen for neuropsychiatric symp-
toms in an elderly neuropsychiatric population (Lange,
Hopp, & Kang, 2004). The NPI-NH has been translated and
validated in the Dutch setting (Kat et al., 2002).
The NPI-NH includes 12 neuropsychiatric symptoms. The
frequency (F) and severity (S) of a particular symptom are
rated on a four- (1–4) and a three-point (1–3) Likert scale,
respectively. A separate score can be calculated for each
symptom by multiplying the frequency and severity scores
(F x S score), resulting in values ranging from zero to 12
for each symptom. The total NPI score is the summed
symptom score and ranges from zero to 144.
We grouped NPI-NH items in neuropsychiatric clusters
after performing a factor analysis (Supplementary data,
Table 1). Factors with eigenvalues >1 were extracted and
orthogonally rotated (varimax). Factors loading 0.4 were
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considered to be relevant. This analysis showed a 4-factor
solution that explained 38.0% of the variance in the data.
The first factor (14.4% of the total variance) represents a clus-
ter “hyperactivity” and has high loadings on irritability, agita-
tion, and disinhibition. The second factor (12.0% of the total
variance) represents a “mood/apathy” cluster and consists of
depression, apathy, and anxiety. The third factor (6.0% of the
total variance) represents a “psychosis” cluster and includes
delusions and hallucinations. The fourth factor (5.5% of the
total variance) solely consists of the item “euphoria”.
Potential determinants of neuropsychiatric symptoms
Cognition was assessed with the Standardized Mini Mental
State Examination (S-MMSE) (Folstein, Folstein, & McHugh,
1975; Molloy, Alemayehu, & Roberts, 1991) and the Frontal
Assessment Battery (FAB) (Dubois, Slachevsky, Litvan, &
Pillon, 2000). The FAB evaluates the following executive
functions: conceptualization, mental flexibility, motor pro-
gramming, sensitivity to interferences, inhibitory control,
and environmental autonomy. The score ranges from 0 to
18, with higher scores indicating better frontal functioning.
Care needs were assessed with the Camberwell
Assessment of Need for the Elderly (CANE) (Reynolds et al.,
2000). The CANE covers 24 areas targeting physical, psy-
chological, social, and environmental needs. Each item can
be assessed as 0¼ no need (no problem), 1¼met need
(the care provided can be considered as appropriate and
potentially of benefit), and 2¼ unmet need (the inter-
viewee experiences a significant care need requiring inter-
vention or assessment, for which currently no or the wrong
kind of help is received). The CANE is applicable in elderly
patients with different levels of cognitive functioning
(Reynolds et al., 2000; van der Roest, Meiland, van Hout,
Jonker, & Droes, 2008).
Analysis
In accordance with previous studies, neuropsychiatric symp-
toms with a FxS score 4 on the NPI-NH were considered
clinically relevant (Cravello, Palmer, de Girolamo, Caltagirone,
& Spalletta, 2011; Lyketsos et al., 2002).
For describing the characteristics of the patient sample,
categorical variables were summarized as percentages and
continuous variables as means (Standard Deviation) or
medians (InterQuartile Range). Comparison of outcomes at
T0 and T1 was performed with Student’s t-tests for paired
samples for normally distributed variables, and with
Wilcoxon Signed Ranks tests if variables were not normally
distributed. Effect sizes (Cohen’s d) were calculated by
dividing the difference between means by the standard
deviation at baseline. In accordance with Cohen’s widely
used rule-of-thumb regarding effect sizes, we consider
d¼ 0.2 as a small, d¼ 0.5 as a medium, and d¼ 0.8 as a
large effect size (Cohen, 1992).
The frequency distributions of neuropsychiatric symp-
toms and the identified symptom clusters were calculated.
We calculated the following frequency parameters for all
patients with complete follow-up: point prevalence (the
proportion of patients with a specific symptom at each
assessment), cumulative prevalence (the percentage of
patients where the symptom was present on at least one
of the two assessments), incidence (the proportion of
patients who had a specific symptom at the second assess-
ment but had no symptoms in the first assessment), and
persistence (the proportion of patients who had a symp-
tom at both of the assessments).
Bivariate analyses (Pearson correlations, analysis of vari-
ance, t-tests) were used to investigate associations between
change in the difference score of the NPI total score, the
NPI cluster hyperactivity, and the NPI cluster mood/apathy
and several possible determinants as based on the litera-
ture (age, sex, level of education, cognitive functioning,
and the number of unmet needs).
Statistical analysis was carried out using SPSS version 22.
Results
Between March 1 2012 and December 31 2014, 180
patients were admitted to the participating GP-NH units. Of
these, 109 patients (mean age 70.1 (SD¼ 12.1) 39.4%
females (n¼ 43)) could not be included in the study due to
dementia and/or inability to give informed consent
(n¼ 43), a physical illness too severe for reliable data col-
lection (n¼ 6), an expected duration of stay of less than
6months (n¼ 21), or no chronic MPM (n¼ 11). Twenty-
eight patients (mean age 71.4 (SD¼ 9.2) 42.9% females
(n¼ 12)) met all the criteria for inclusion, but gave no
informed consent or this could not be obtained in time,
leaving 71 patients to be included. For 8 of them, no data
could be collected at T1 because of death (n¼ 5), reloca-
tion (n¼ 2) and withdrawal from the study (n¼ 1). So, for
63 patients data were collected at both T0 and T1.
Demographic and clinical characteristics
The patient sample consisted of slightly more women than
men, with a mean age of almost 70 years (Table 1). Almost
half of them stayed in a psychiatric hospital before being
admitted to the GP-NH unit.
Neuropsychiatric symptoms
The mean total NPI FxS score increased from 25.3
(SD¼ 17.5) at T0 to 29.3 (SD¼ 16.5) at T1 (t¼2.044,
Table 1. Characteristics of the patient sample (N¼ 71).
Characteristic % (n)
Age, ya 69.3 (SD 10.5)
Sex (% female) 56.3% (40)
Country of origin










Residence prior to admission to the GP-NH
unit
Psychiatric hospital 46.5% (33)
Nursing home 23.9% (17)
Care home 14.1% (10)
Home 7.0% (5)
Other 8.5% (6)
Number of chronic medical disordersa 6.8 (SD 2.7)
Number of chronic psychiatric disordersa 2.2 (SD 0.9)
aMean, SD.
b1 missing.
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df¼ 62, p¼ 0.045, Cohen’s d¼0.23). The mean FxS score
increased from 9.7 (SD¼ 8.7) at T0 to 11.8 (SD¼ 9.0) at T1
in the cluster hyperactivity (Z¼2.065, p¼ 0.039, Cohen’s
d¼0.24), and from 7.7 (SD¼ 7.7) at T0 to 10.1 (SD¼ 9.4)
at T1 in the cluster mood/apathy (Z¼2.651, p¼ 0.008,
Cohen’s d¼0.31).
As Table 2 shows, overall NPS were very frequent: 87.3%
(n¼ 55) of the patients had at least one clinically relevant
symptom and 42.9% (n¼ 27) had more than 3 symptoms
simultaneously at T0. At T1, 87.3% (n¼ 55) and 54.0%
(n¼ 34) had at least one and four symptoms respectively.
Just over 95% had any symptom at T0 and/or T1, of which
irritability was the most prevalent and persistent symptom
and the symptom with the highest incidence. Depression
was also notable for its high persistence. Hyperactivity was
the most prevalent and persistent symptom cluster.
A lower FAB score at baseline was related to a more
positive difference score on hyperactivity (less frequency x
severity at T1 than at T0) (Table 3). Other significant rela-
tionships were not found.
Psychotropic drug use
Patients used a mean number of 2.5 (SD¼ 1.5) psycho-
tropic drugs at T0 and 2.4 (SD¼ 1.5) at T1. The proportion
of patients using a particular class of psychotropic drugs is
shown in Table 4.
In addition to the results shown in Table 4, we found
that 90.5% (n¼ 57) used at least one psychotropic drug at
T0 and/or T1. In total, it concerned 167 prescriptions. Two-
thirds of the prescriptions (66.5%, n¼ 111) were exactly the
same at T0 and T1. In 19.2% (n¼ 32) of the patients a new
psychotropic drug was prescribed and/or the dose was
increased, and in 14.4% (n¼ 24) a prescription was discon-
tinued and/or the dose was decreased. Starting (n¼ 9) and
stopping (n¼ 6) a prescription was most common with ben-
zodiazepines (n¼ 45). In 19.6% (n¼ 10) of the antipsychotic
prescriptions (n¼ 51) the dose was higher at T1 than at T0.
Discussion
This first study on the natural course in NPS in nursing
home patients with MPM no dementia in the first 8months
Table 2. Frequency parameters of clinically relevant NPS (FxS 4) in patients with complete follow-up (N¼ 63) on individual items and identified clusters;








Delusions 33.3% (21) 25.4% (16) 39.7% (25) 9.5% (4) 57.1% (12)
Hallucinations 11.1% (7) 11.1% (7) 17.5% (11) 7.1% (4) 42.9% (3)
Agitation 47.6% (30) 50.8% (32) 68.3% (43) 39.4% (13) 63.3% (19)
Depression 30.2% (19) 47.6% (30) 52.4% (33) 31.8% (14) 84.2% (16)
Anxiety 25.4% (16) 39.7% (25) 50.8% (32) 34.0% (16) 56.3% (9)
Euphoria 6.3% (4) 4.8% (3) 7.9% (5) 1.7% (1) 50.0% (2)
Apathy 33.3% (21) 39.7% (25) 50.8% (32) 26.2% (11) 66.7% (14)
Disinhibition 23.8% (15) 33.3% (21) 42.9% (27) 25.0% (12) 60.0% (9)
Irritability 52.4% (33) 65.1% (41) 71.4% (45) 40.0% (12) 87.9% (29)
Aberrant motor behavior 9.5% (6) 7.9% (5) 14.3% (9) 5.3% (3) 33.3% (2)
Night time disturbances 11.1% (7) 12.7% (8) 19.0% (12) 8.9% (5) 42.9% (3)
Eating changes 28.6% (18) 22.2% (14) 34.9% (22) 8.9% (4) 55.6% (10)
Neuropsychiatric symptom clusters:
Hyperactivity 61.9% (39) 73.0% (46) 81.0% (51) 50.0% (12) 87.2% (34)
Mood/apathy 57.1% (36) 66.7% (42) 79.4% (50) 51.9% (14) 77.8% (28)
Psychosis 34.9% (22) 28.6% (18) 42.9% (27) 12.2% (5) 59.1% (13)
Other neuropsychiatric symptom counts:
Any symptom 87.3% (55) 87.3% (55) 95.2% (60) 62.5% (5) 90.9% (50)
More than 3 symptoms 42.9% (27) 54.0% (34) 63.5% (40) 36.1% (13) 77.8% (21)
aThe ratio of residents with clinically relevant NPS at follow-up to residents without clinically relevant NPS at baseline.
bThe ratio of residents with clinically relevant NPS at follow-up to residents with clinically relevant NPS at baseline.
Table 3. Bivariate relationships between potential determinants and the NPI FxS difference score.
FxS difference score NPI total
(T0-T1)
FxS difference score NPI
hyperactivity (T0-T1)
FxS difference score NPI
mood/apathy (T0-T1)
Pearson’s r Sig (2-tailed) Pearson’s r Sig (2-tailed) Spearman’s rho Sig (2-tailed)
Age 0.151 0.239 0.131 0.307 0.069 0.589
MMSE score 0.023 0.861 0.040 0.759 0.063 0.627
FAB score 0.165 0.209 0.287 0.026 0.018 0.890
Number of unmet needs 0.010 0.938 0.091 0.477 0.029 0.823
Student’s t Sig (2-tailed) Student’s t Sig (2-tailed) Student’s t Sig (2-tailed)
Sex 0.027 0.979 0.852 0.398 0.193 0.848
ANOVA F Sig (2-tailed) ANOVA F Sig (2-tailed) ANOVA F Sig (2-tailed)
Level of education 2.583 0.084 0.298 0.743 2.424 0.097
Table 4. Proportion of patients using psychotropic drugs (N¼ 63).
T0 T1
Mean number of psychotropic drugsa 2.5 (SD 1.5) 2.4 (SD 1.5)
Antipsychotics 58.7% (37) 58.7% (37)
Anxiolytics 31.7% (20) 36.5% (23)
Hypnotics 22.2% (14) 20.6% (13)
Antidepressants 57.1% (36) 52.4% (33)
Antiepilepticsb 31.7% (20) 30.2% (19)
Anti-dementia drugs 3.2% (2) 1.6% (1)
Drugs used in addictive disorders 1.6% (1) 1.6% (1)
Psychotropics (total) 88.9% (56) 87.3% (55)
aMean, SD.
bPatients with epilepsy n¼ 10; patients with neuropathic pain n¼ 1.
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after admission to a GP-NH unit, showed a significant
increase of the NPI FxS score concerning the total score of
the 12 NPI items, the total score of the hyperactivity clus-
ter, and the total score of the mood/apathy cluster.
Overall NPS were very frequent. Just over 95% had any
clinically relevant symptom at T0 and/or T1, of which irri-
tability was the most prevalent and persistent symptom
and the symptom with the highest incidence. Hyperactivity
was the most prevalent and persistent symptom cluster.
Also, depression had a high persistence.
Firstly, we compared our follow-up results with the
results of the NH patients with MPM (with and without
dementia) in the cross sectional SpeCIMeN study, the only
study that is fairly akin to our study in terms of study
population and assessment instruments (Collet et al., 2018).
Similar symptoms appeared to be most prevalent, although
the prevalence rates were higher in our study. Our study
extends these findings by having longitudinal results.
Unfortunately, there are no longitudinal studies of NH
patients with MPM. Longitudinal studies in NH patients
with dementia (Bergh, Engedal, Røen, & Selbaek, 2011;
Selbaek et al., 2014; Wetzels et al., 2010), showed similar
NPS that occurred most frequently, with our prevalence
rates generally being slightly higher at both measurements.
In our study, as well as in two of the dementia studies, irri-
tability was the most prevalent NPS and increased between
the baseline and first follow-up assessment. In all studies,
one of the hyperactivity symptoms had the highest inci-
dence and persistence. The dementia studies, by contrast,
showed considerably higher prevalence, incidence, and per-
sistence rates for aberrant motor behaviour than our study.
Although patients with MPM have different clinical char-
acteristics than patients with dementia, the high preva-
lence rate of hyperactivity symptoms stands out in both
groups. These are symptoms that have been shown to con-
tribute to admission to a nursing home in people with
dementia (Cerejeira, Lagarto, & Mukaetova-Ladinska, 2012).
This probably also applies to patients with MPM no
dementia, because these symptoms cause a great burden
for (informal) caregivers, regardless of the underlying
diagnosis.
We also found depression was highly persistent. This is
not surprising because ‘having a chronic psychiatric or
behavioural problem’ was one of the inclusion criteria.
Finally, we found a slight increase in the total FxS score
of the NPI, which was mainly caused by the increased FxS
scores of the hyperactivity- and mood/apathy-items. This
finding is not in line with the results of a recent systematic
literature review of studies investigating the course of NPS
in NH patients with dementia showing that NPS were sta-
ble or decreased after admission to NH (Selbaek, Engedal,
& Bergh, 2013).
Although the change we found was statistically signifi-
cant, the effect size was small and the mean increase of 4
points was less than previous studies have indicated as
clinically meaningful (18–22 points in acute geriatric neuro-
psychiatric inpatients (Iverson, Hopp, DeWolfe, & Solomons,
2002), 11 points in nursing home patients with dementia
(Zuidema et al., 2011), and 9 points in outpatients with
dementia (Kaufer, Cummings, & Christine, 1996)). Hence,
the clinical relevance of the change found in NPI total
score may be limited.
In aiming to explain our findings, the found increase in
the prevalence rates of most NPS as well as in the total
FxS score, was probably not considerably influenced by
changes in PDU, since most prescriptions remained
unchanged at follow up.
Alternatively, the results may partially be explained by
the design of the study. Acknowledging that admission to
a GP-NH itself is an intervention aimed to improve func-
tioning, the baseline should be conducted prior to admis-
sion as usually done in pre-post designs (Thiese, 2014). In
the MAPPING study, the assessment at baseline was per-
formed 6–8weeks after admission. This may have led to an
underestimation of decreases in NPS, as the largest
improvement of psychological symptoms usually happen
within the first weeks after an intervention is administered
(in this case: the admission to a GP-NH unit). Based on our
clinical experience, we think that many patients have
responded positively to the new social contacts and activ-
ities, and the personal attention they have received from
the staff that was aiming to draw up an individual care
plan. So, most improvement might have occurred before
the first assessment.
Nevertheless, we must not close our eyes to the possibil-
ity that our findings also could indicate a non-optimal care
setting for the studied patient group. Possibly, the support-
ive environment of a GP-NH unit does not sufficiently
match the needs of patients with MPM. There is a risk that
NHs, from their proficiency in caring for residents with
dementia, provide an environment that is too supportive
for patients with MPM. Based on the experience of inpatient
mental health, it seems to be appropriate to create a more
therapeutic milieu on GP-NH units (van den Brink et al.,
2014). In addition, daytime activities may not be sufficiently
adapted to the wishes and capabilities of these patients of
whom several are relatively young (van den Brink, Gerritsen,
Oude Voshaar, & Koopmans, 2013). Finally, there is also the
possibility that the expertise of the staff may be insufficient
to optimally meet the complex care needs of patients with
MPM (van den Brink et al., 2018).
Strengths and limitations
In this study, the NPI questionnaires were completed in the
form of structured interviews. Since the interviews were
conducted by two elderly-care physicians who were familiar
with this patient group and their professional careers, the
data are of high quality and there were few missing data.
However, some limitations must be mentioned.
Firstly, in our study, behavioural problems were opera-
tionalized as NPS. NPS were assessed with the NPI-NH
which is a validated measure instrument in our study
population (Lange et al., 2004). However, the NPI relies on
information from a licensed nurse who has observed the
patient over the past four weeks. The correct unravelling of
behaviour in symptoms is a difficult task for the nursing
staff for which they may not have been adequately trained.
Furthermore, the results may be influenced by the attitude
of the nurse. Moreover, the broad perspective on behav-
iour is narrowed down to a symptom approach when
studying behavioural problems by assessing NPS with the
NPI. This could be considered as potentially inaccurate and
misleading (Caspi, 2013; Macaulay, 2018).
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Secondly, the sample size and the heterogeneity of the
study population, due to diversity in the composition of
the multimorbidity per individual, have limited the possibil-
ity to find out determinants of NPS. In addition, this study
included only one follow-up assessment after 6months.
Participants’ NPS may have fluctuated in this period rather
than being persistent or consequently deteriorating.
Finally, study participants were recruited from special-
ized GP units in several Dutch NHs. These units have vary-
ing criteria for admission depending on, for example, the
qualitative and quantitative composition of the multidisci-
plinary team and cooperation agreements with mental and
other healthcare services. As the MAPPING study is an
explorative, descriptive study with a small sample size, we
did not investigate the effect of these criteria on the com-
position of the study population. We tried to reduce this
impact by using inclusion criteria at the individual patient
level and not at the level of the unit. Nevertheless, differ-
ent profiles in GP-NH units could have influenced the
severity of NPS.
Despite these limitations, we believe that the findings in
this first explorative and descriptive longitudinal study
showed valuable results for clinical practice which require
and justify further research.
Conclusion and recommendations
In conclusion, our results indicate the omnipresence of NPS
of which most were found to be persistent.
Future studies with larger samples and longer follow-up
periods in which more assessments are performed, are neces-
sary to not only gain a better insight in the course of NPS
and its determinants but also to assess the effect of interven-
tions. After all, it remains a purpose of LTC to reduce
patients’ NPS and several opportunities for this may exist.
First of all a therapeutic milieu could be created includ-
ing the following practices: containment (meeting the basic
needs and providing physical care and safety to the people
within the environment), support (giving kindness as the
basis for a structure that fosters predictability and control),
structure (having a predictable organization of roles and
responsibilities as well as setting limits when necessary),
involvement (practices in which the resident engages in
the social environment) and validation (affirming a resi-
dent’s individuality) (Gunderson, 1978; Mahoney, Palyo,
Napier, & Giordano, 2009).
Secondly, a specialized multidisciplinary team could be
composed of which all members have appropriate know-
ledge and skills to identify signs of mental and physical dis-
ruptions at an early stage. If there is a lack of knowledge
and/or skills, staff education is indispensable.
Finally, it could be worthwhile to investigate whether
thought-out changes in PDU cause reduction in NPS.
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